Acadia Healthcare Raises 2026 Guidance on Strong Q3 Growth

  • Acadia Healthcare reported $895.3 million in Q3 2026 revenue, up 5.1% YoY.
  • Same-facility revenue increased 5.2%, driven by a 1.1% rise in patient days and a 4.0% increase in revenue per patient day.
  • Adjusted EBITDA rose to $176.4 million, up from $173.0 million in Q3 2025.
  • The company added 220 licensed beds, including a 144-bed facility near Jacksonville, Florida.
  • Full-year 2026 guidance was raised, with revenue now expected between $3.44B and $3.46B.

Acadia Healthcare's Q3 2026 results reflect continued growth in the behavioral healthcare sector, driven by increased patient demand and strategic facility expansions. The company's raised full-year guidance underscores its confidence in sustaining this momentum, despite potential regulatory headwinds from the OBBBA. As the largest stand-alone behavioral healthcare provider in the U.S., Acadia's performance offers insights into the broader trends in mental health and addiction treatment services.

Expansion Strategy
How Acadia's addition of 220 licensed beds will impact its operational efficiency and market reach.
Regulatory Impact
Whether the One Big Beautiful Bill Act (OBBBA) will affect Acadia's revenue streams and operational costs.
Financial Discipline
The pace at which Acadia can maintain its financial discipline while expanding its footprint.